NCT00207701View on ClinicalTrials.gov

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

PHASE3CompletedINTERVENTIONAL

Enrollment

279

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

February 28, 2005

Conditions

Ankylosing Spondylitis

Interventions

DRUG

infliximab

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Centocor BV

INDUSTRY

lead

Centocor, Inc.

INDUSTRY